US 12257224
Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker
granted A61KA61K31/277A61K31/7048
Quick answer
US patent 12257224 (Methods of administration for highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker) held by Milestone Pharmaceuticals Inc. expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Milestone Pharmaceuticals Inc.
- Grant date
- Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/277, A61K31/7048, A61K31/7076, A61K45/06